SNRPB

Across TCGA pan-cancer cohorts, SNRPB mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SNRPB data layer compared with 28 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher SNRPB mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNRPB expression acts as an unfavorable survival marker.

LSCC and HNSC are the cancer types where SNRPB mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Tertile	All	0.437	0.895	.001	21	view →
HNSC	DFS	Median	III,IV	0.879	1.000	.020	11	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SNRPB–LSCC (DFS)

Open the LSCC breakdown →